Biblio Discovery — Demo Discovery Service

9 results for "Purnima Pathak"

Showing 1–9 · 0.51 seconds · RSS

  1. Journal Article

    Molecular diversity analysis of rough lemon (Citrus jambhiri Lush.) in different agroclimatic zones of Assam

    Purnima Pathak; Aradhana Phukan; Bhupen Kumar Baishya et al.

    Electronic Journal of Plant Breeding, Vol. 17 No. 2 · 2026 · English · DOAJ Scopus

    Rough lemon (Citrus jambhiri Lush.) is an important rootstock in Citrus group. Being indigenous to North-Eastern part of India, a wide variability has been observed in the region particularly in the state of Assam. However, not much evolved types have been reported in due course of time. SSR…

  2. Journal Article Full text

    Effect of ribociclib on productivity losses due to breast cancer in young women in Brazil

    Anna Maria Buehler; Pierre-Alexandre Dionne; David Chandiwana et al.

    Revista de Saúde Pública, Vol. 56 · 2022 · Portuguese · DOAJ Scopus

    ABSTRACT OBJETIVE To evaluate the effect of ribociclib versus endocrine therapy on productivity losses due to advanced breast cancer. METHODS Productivity data from the MONALEESA-7 trial, obtained from the results of the application of the Work Productivity and Activity Impairment (WPAI)…

  3. Journal Article

    Patients' perspectives on COPD: findings from a social media listening study

    Nigel S. Cook; Konstantinos Kostikas; Jean-Bernard Gruenberger et al.

    ERJ Open Research, Vol. 5 No. 1 · 2019 · English · DOAJ Scopus

    We utilised social media listening (SML) to obtain patients' perspectives on symptoms, diagnosis and comorbidities associated with chronic obstructive pulmonary disease (COPD) and its impact on patients' quality of life (QoL). A comprehensive search on social media platforms was performed for…

  4. Journal Article

    Matching-adjusted indirect comparison of PFS and OS comparing ribociclib plus letrozole palbociclib plus letrozole as first-line treatment of HR+/HER2− advanced breast cancer

    Komal Jhaveri; Joyce O’Shaughnessy; Peter A. Fasching et al.

    Therapeutic Advances in Medical Oncology, Vol. 15 · 2023 · English · DOAJ Scopus

    Background: Current standard-of-care first-line treatment of patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2−) advanced breast cancer (ABC) is cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) + endocrine therapy. In the MONALEESA-2 trial…

  5. Journal Article

    Quality of life with ribociclib abemaciclib as first-line treatment of HR+/HER2− advanced breast cancer: a matching-adjusted indirect comparison

    Hope S. Rugo; Victoria Harmer; Joyce O’Shaughnessy et al.

    Therapeutic Advances in Medical Oncology, Vol. 15 · 2023 · English · DOAJ Scopus

    Background: A cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) + endocrine therapy is recommended as first-line treatment for hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2−) advanced breast cancer (ABC). Quality of life (QoL) is an important endpoint that…

  6. Journal Article

    Real-world risk of recurrence and treatment outcomes with adjuvant endocrine therapy in patients with stage II-III HR+/HER2- early breast cancer

    Joyce O'Shaughnessy; Sara M. Tolaney; Denise A. Yardley et al.

    Breast, Vol. 81 · 2025 · English · DOAJ Scopus

    Abstract (246 words): Background: Despite adjuvant endocrine therapy (ET), recurrence is still a concern for patients with HR+/HER2- early breast cancer (EBC). We assessed recurrence risk in real-world patients with stage II/III HR+/HER2- EBC treated with adjuvant ET. Methods: A retrospective…

  7. Journal Article

    Correlation between work productivity loss and EORTC QLQ-C30 and -BR23 domains from the MONALEESA-7 trial of premenopausal women with HR+/HER2− advanced breast cancer

    Debu Tripathy; Tristan Curteis; Sara Hurvitz et al.

    Therapeutic Advances in Medical Oncology, Vol. 14 · 2022 · English · DOAJ Scopus

    Background: The phase III MONALEESA-7 trial (NCT02278120) assessed ribociclib + endocrine therapy (ET) versus ET in premenopausal women with HR+/HER2− advanced breast cancer (ABC). The relationship between work productivity loss (WPL) and domains of European Organisation for Research and Treatment…

  8. Journal Article

    Development and content validation of a self-completed, electronic Pediatric Asthma Symptom Diary

    Marci Clark; Carla Romano; Oyebimpe Olayinka-Amao et al.

    Journal of Patient-Reported Outcomes, Vol. 6 No. 1 · 2022 · English · DOAJ Scopus

    Abstract Background Childhood asthma is an important unmet need. To date, patient-reported outcome measures (PROMs) for children with asthma have used a combination of caregiver or proxy-reported and self-reported measures. No comprehensive measure is available to assess the severity and impact of…